Evaluation of Safety & Efficacy of MIR 19 ® Inhalation Solution in Patients With Mild COVID-19
Clinical trial NCT05783206 · COMPLETED
Trial details
- NCT number
- NCT05783206
- Sponsor
- National Research Center - Institute of Immunology Federal Medical-Biological Agency of Russia
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-10
- Primary completion
- 2023-07-28
- Enrollment
- 984
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.